Zynrelef
Active Ingredient(s): Bupivacaine + MeloxicamFDA Approved: * May 12, 2021
Pharm Company: * Heron Therapeutics, Inc.
Category: Anesthetic
Bupivacaine/meloxicam, sold under the brand name Zynrelef, is a fixed-dose combination medication used to treat pain in small to medium-sized wounds after surgery.[1][2][3] It contains bupivacaine and meloxicam.[1][2] The most common side effects of bupivacaine/meloxicam are dizziness, constipation, vomiting, and headache.[1][2] It was approved for medical use in the European Union ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.